| |
+LN n=30 |
-LN n=72 |
Control n=31 |
Univariate β |
p-value |
| s-BAFF ng/μl |
2.09 ±1.14 |
1.91 ±1.09 |
0.97 ±0.27 |
0.57 |
<0.001 |
| BAFF-RQ |
1.88 ±0.60 |
1.75 ±0.64 |
1.12 ±0.64 |
0.38 |
<0.001 |
| NK cells, 109/L |
0.13 ±0.10 |
0.13±0.08 |
0.26 ±0.11 |
-0.05 |
0.002 |
| CD4 cells, 109/L |
0.53 ±0.30 |
0.64 ±0.33 |
1.0 ±0.33 |
-0.20 |
<0.001 |
| C3, g/L |
0.83 ±0.31 |
1.01 ±0.24 |
1.19 ±0.27 |
-0.18 |
<0.001 |
| C4, g/L |
0.13 ±0.06 |
0.17 ±0.07 |
0.22 ±0.05 |
-0.04 |
<0.001 |
| Hb, g/L |
12.5 ±2.0 |
13.2 ±1.5 |
13.5 ±1.7 |
-0.48 |
0.021 |
| Albumen, g/L |
40.3 ±4.8 |
43.5 ±2.9 |
44.8 ±2.5 |
-2.37 |
<0.001 |
| Fibrinogen, g/L |
3.9 ±0.7 |
3.4 ±0.8 |
3.4 ±0.7 |
0.25 |
0.028 |
| vWF (%) |
121 ±28 |
109 ±32 |
87 ±37 |
16.0 |
0.001 |
| Faktor VIII (%) |
148 ±23 |
134 ±29 |
120 ±36 |
14.2 |
0.002 |
| vWF antigen (%) |
143 ±31 |
136 ±34 |
106 ±36 |
16.8 |
0.001 |
| LDH, U/L |
206 ±105 |
177 ±57 |
155 ±17 |
25.9 |
0.015 |
| Homocysteine, µmol/L |
12.9 ±7.9 |
10.4 ±4.3 |
8.8 ±2.6 |
2.16 |
0.011 |
| PTH, pmol/L |
9.6 ±16.7 |
5.2 ±2.1 |
4.5 ±1.7 |
2.78 |
0.026 |
| Ionized Ca, mmol/L |
1.22 ±0.04 |
1.28 ±0.59 |
1.23 ±0.03 |
-0.02 |
0.8 |
| Haptoglobin, g/L |
1.51 ±0.63 |
1.34 ±0.67 |
1.43 ±0.58 |
0.06 |
0.5 |
| AGP, g/L |
1.05 ±0.36 |
0.96 ±0.33 |
0.87 ±0.19 |
0.09 |
0.1 |
| Apolipoprotein A, g/L |
1.61 ±0.34 |
1.52 ±0.38 |
1.47 ±0.38 |
0.07 |
0.2 |
| C1 inhibitor, g/L |
0.34 ±0.06 |
0.33 ±0.07 |
0.30 ±0.04 |
0.02 |
0.047 |
BAFF-RQ; BAFF gene expression; vWF; vonWillebrand factor, PTH; Parathyreoid hormone, AGP; α-1-acid-glycoprotein, LDH; Lactate dehydrogenase |
